Anti-PRAME Immunotherapeutic GSK2302032A

Preferred Label : Anti-PRAME Immunotherapeutic GSK2302032A;

NCIt synonyms : PRAME ASCI;

NCIt definition : An immunotherapeutic agent targeting the tumor-associated antigen (TAA), preferentially expressed antigen of melanoma (PRAME), with potential antineoplastic activity.;

Molecule name : GSK-2302032A;

NCI Metathesaurus CUI : CL421661;

Details

Origin ID

C116848;

UMLS CUI

C3896844;

Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]
has_target
- Melanoma Antigen Preferentially Expressed in Tumors [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients